tradingkey.logo

Inogen Inc

INGN
6.750USD
+0.040+0.60%
收盘 12/22, 16:00美东报价延迟15分钟
183.25M总市值
亏损市盈率 TTM

Inogen Inc

6.750
+0.040+0.60%

关于 Inogen Inc 公司

Inogen, Inc. is a medical technology company offering respiratory products for use in the homecare setting. It supports patient respiratory care by developing, manufacturing, and marketing portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Its Inogen One and Inogen Rove systems concentrate the air around the patient to offer a source of supplemental oxygen with a battery and can be plugged into an outlet when at home, in a car, or in a public place with outlets available. Its Inogen One and Inogen Rove systems reduce the patient’s reliance on stationary concentrators and scheduled deliveries of tanks with a finite supply of oxygen. Inogen Connect is a wireless connectivity platform for the Inogen One G4, Inogen One G5, Inogen Rove 4, and Inogen Rove 6, consisting of a front-end mobile application for use by long-term oxygen therapy users. It offers Simeox, which is an airway clearance device.

Inogen Inc简介

公司代码INGN
公司名称Inogen Inc
上市日期Feb 14, 2014
CEOSmith (Kevin R. M)
员工数量766
证券类型Ordinary Share
年结日Feb 14
公司地址859 Ward Drive
城市GOLETA
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编93111
电话18055620500
网址https://www.inogen.com/
公司代码INGN
上市日期Feb 14, 2014
CEOSmith (Kevin R. M)

Inogen Inc公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Kevin M. King
Mr. Kevin M. King
Independent Director
Independent Director
55.01K
+125.45%
Mr. Glenn S. Boehnlein, CPA
Mr. Glenn S. Boehnlein, CPA
Independent Director
Independent Director
55.01K
+125.45%
Mr. Michael J. Bourque
Mr. Michael J. Bourque
Chief Financial Officer, Executive Vice President, Corporate Treasurer
Chief Financial Officer, Executive Vice President, Corporate Treasurer
49.15K
+3.15%
Mr. Gregoire Ramade
Mr. Gregoire Ramade
Executive Vice President, Chief Commercial Officer
Executive Vice President, Chief Commercial Officer
37.25K
+100.00%
Ms. Mira Sahney
Ms. Mira Sahney
Independent Director
Independent Director
30.61K
--
Mr. Naga Rameswamy
Mr. Naga Rameswamy
Chief Technology Officer
Chief Technology Officer
--
--
Ms. Jennifer Boyer
Ms. Jennifer Boyer
Chief Human Resources Officer, Executive Vice President - Enterprise Enablement
Chief Human Resources Officer, Executive Vice President - Enterprise Enablement
--
--
Mr. Kevin P. Smith
Mr. Kevin P. Smith
Executive Vice President - Business Development, General Counsel, Secretary
Executive Vice President - Business Development, General Counsel, Secretary
--
--
Ms. Elizabeth (Beth) Mora, CPA
Ms. Elizabeth (Beth) Mora, CPA
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Kevin R. M. Smith
Mr. Kevin R. M. Smith
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Kevin M. King
Mr. Kevin M. King
Independent Director
Independent Director
55.01K
+125.45%
Mr. Glenn S. Boehnlein, CPA
Mr. Glenn S. Boehnlein, CPA
Independent Director
Independent Director
55.01K
+125.45%
Mr. Michael J. Bourque
Mr. Michael J. Bourque
Chief Financial Officer, Executive Vice President, Corporate Treasurer
Chief Financial Officer, Executive Vice President, Corporate Treasurer
49.15K
+3.15%
Mr. Gregoire Ramade
Mr. Gregoire Ramade
Executive Vice President, Chief Commercial Officer
Executive Vice President, Chief Commercial Officer
37.25K
+100.00%
Ms. Mira Sahney
Ms. Mira Sahney
Independent Director
Independent Director
30.61K
--
Mr. Naga Rameswamy
Mr. Naga Rameswamy
Chief Technology Officer
Chief Technology Officer
--
--

收入明细

单位: USD更新时间: 10月6日 周一
单位: USD更新时间: 10月6日 周一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
由于公司未披露,未能获取相关数据
地区USD
名称
营收
占比
U.S. revenue
56.35M
61.07%
Non-U.S. revenue
35.92M
38.93%
业务
地区
由于公司未披露,未能获取相关数据

股东统计

更新时间: 11月17日 周一
更新时间: 11月17日 周一
持股股东
股东类型
持股股东
持股股东
占比
Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.- 20211st Phase ESOP
9.67%
BlackRock Institutional Trust Company, N.A.
5.50%
The Vanguard Group, Inc.
5.27%
Acadian Asset Management LLC
3.93%
Camber Capital Management LP
3.59%
其他
72.04%
持股股东
持股股东
占比
Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.- 20211st Phase ESOP
9.67%
BlackRock Institutional Trust Company, N.A.
5.50%
The Vanguard Group, Inc.
5.27%
Acadian Asset Management LLC
3.93%
Camber Capital Management LP
3.59%
其他
72.04%
股东类型
持股股东
占比
Investment Advisor
25.98%
Investment Advisor/Hedge Fund
25.85%
Hedge Fund
18.26%
Corporation
9.67%
Individual Investor
2.48%
Research Firm
1.98%
Family Office
0.89%
Pension Fund
0.27%
Bank and Trust
0.20%
其他
14.42%

机构持股

更新时间: 10月1日 周三
更新时间: 10月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2025Q3
308
19.98M
73.65%
-4.59M
2025Q2
330
22.77M
84.68%
-2.73M
2025Q1
372
22.71M
84.47%
-2.93M
2024Q4
375
21.79M
82.19%
-5.25M
2024Q3
367
21.78M
91.28%
-6.90M
2024Q2
360
23.19M
97.91%
-6.59M
2024Q1
364
22.78M
97.44%
-4.92M
2023Q4
369
22.26M
95.31%
-4.56M
2023Q3
386
22.05M
94.85%
-5.76M
2023Q2
403
22.24M
96.20%
-5.90M
查看更多

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.- 20211st Phase ESOP
2.63M
9.71%
+2.63M
--
Feb 21, 2025
BlackRock Institutional Trust Company, N.A.
1.52M
5.61%
-63.70K
-4.03%
Jun 30, 2025
The Vanguard Group, Inc.
1.65M
6.12%
+113.18K
+7.35%
Jun 30, 2025
Acadian Asset Management LLC
1.02M
3.76%
-11.08K
-1.08%
Jun 30, 2025
Camber Capital Management LP
975.00K
3.61%
--
--
Jun 30, 2025
Armistice Capital LLC
664.00K
2.46%
+664.00K
--
Jun 30, 2025
Columbia Threadneedle Investments (US)
881.10K
3.26%
+6.57K
+0.75%
Jun 30, 2025
Dimensional Fund Advisors, L.P.
832.19K
3.08%
+75.07K
+9.91%
Jun 30, 2025
Geode Capital Management, L.L.C.
615.28K
2.28%
+44.86K
+7.86%
Jun 30, 2025
Dafna Capital Management, LLC
605.63K
2.24%
+147.56K
+32.21%
Jun 30, 2025
查看更多

持股ETF

更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
Cultivar ETF
0.59%
Invesco NASDAQ Future Gen 200 ETF
0.55%
Federated Hermes MDT Small Cap Core ETF
0.25%
JPMorgan Fundamental Data Science Small Core ETF
0.11%
iShares Micro-Cap ETF
0.04%
Avantis US Small Cap Equity ETF
0.02%
Proshares Ultra Russell 2000
0.01%
ProShares Hedge Replication ETF
0.01%
ProShares UltraPro Russell2000
0.01%
Global X Russell 2000 ETF
0.01%
查看更多
Cultivar ETF
占比0.59%
Invesco NASDAQ Future Gen 200 ETF
占比0.55%
Federated Hermes MDT Small Cap Core ETF
占比0.25%
JPMorgan Fundamental Data Science Small Core ETF
占比0.11%
iShares Micro-Cap ETF
占比0.04%
Avantis US Small Cap Equity ETF
占比0.02%
Proshares Ultra Russell 2000
占比0.01%
ProShares Hedge Replication ETF
占比0.01%
ProShares UltraPro Russell2000
占比0.01%
Global X Russell 2000 ETF
占比0.01%

分红派息

近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据

拆合股

公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据

常见问题

Inogen Inc的前五大股东是谁?

Inogen Inc 的前五大股东如下:
Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.- 20211st Phase ESOP持有股份:2.63M,占总股份比例:9.71%。
BlackRock Institutional Trust Company, N.A.持有股份:1.52M,占总股份比例:5.61%。
The Vanguard Group, Inc.持有股份:1.65M,占总股份比例:6.12%。
Acadian Asset Management LLC持有股份:1.02M,占总股份比例:3.76%。
Camber Capital Management LP持有股份:975.00K,占总股份比例:3.61%。

Inogen Inc的前三大股东类型是什么?

Inogen Inc 的前三大股东类型分别是:
Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.- 20211st Phase ESOP
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.

有多少机构持有Inogen Inc(INGN)的股份?

截至2025Q3,共有308家机构持有Inogen Inc的股份,合计持有的股份价值约为19.98M,占公司总股份的73.65%。与2025Q2相比,机构持股有所增加,增幅为-11.03%。

哪个业务部门对Inogen Inc的收入贡献最大?

在FY2025Q2,--业务部门对Inogen Inc的收入贡献最大,创收--,占总收入的--%。
KeyAI